These Analysts Revise Their Forecasts On Cerebras Systems Following Q2 Results

Benzinga Earnings

08/13

Cerebras Systems Inc (NASDAQ:CBRS) on Wednesday reported worse-than-expected quarterly sales.

Cerebras Systems reported GAAP quarterly losses of $2.98 per share, according to Benzinga Pro data. Quarterly revenue came in at $180.11 million which missed the Street estimate of $194.2 million by 7.26%.

"This was an outstanding quarter for Cerebras. Core revenue more than doubled to $210 million, and our cloud business nearly quadrupled year-over-year," said Andrew Feldman, Cerebras co-founder and CEO.

Cerebras Systems shares dipped 17.6% to $215.98 in pre-market trading.

These analysts made changes to their price targets on Cerebras Systems following earnings announcement.

Morgan Stanley analyst Joseph Moore maintained the stock with an Overweight rating and raised the price target from $273 to $279.
Mizuho analyst Vijay Rakesh maintained the stock with an Outperform rating and lowered the price target from $310 to $300.
Wedbush analyst Matt Bryson maintained the stock with an Outperform rating and raised the price target from $280 to $290.

Considering buying CBRS stock? Here’s what analysts think:

Photo via Shutterstock

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/2659157123"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2659157123\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2659157123?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-13 21:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2659157123","market":"hk","top_or_hot":-1,"title":"These Analysts Revise Their Forecasts On Cerebras Systems Following Q2 Results","media":"Benzinga Earnings","content":"<html><body><p><strong><a href=\"https://laohu8.com/S/CBRS\">Cerebras Systems</a> Inc</strong> (NASDAQ:CBRS) on Wednesday reported worse-than-expected quarterly sales.</p>\n<p>Cerebras Systems reported GAAP quarterly losses of $2.98 per share, according to Benzinga Pro data. Quarterly revenue came in at $180.11 million which missed the Street estimate of $194.2 million by 7.26%.</p>\n<p>\"This was an outstanding quarter for Cerebras. Core revenue more than doubled to $210 million, and our cloud business nearly quadrupled year-over-year,\" said Andrew Feldman, Cerebras co-founder and CEO.</p>\n<p>Cerebras Systems shares dipped 17.6% to $215.98 in pre-market trading.</p>\n<p>These analysts made changes to their price targets on Cerebras Systems following earnings announcement.</p>\n<ul>\n<li>Morgan Stanley analyst Joseph Moore maintained the stock with an Overweight rating and raised the price target from $273 to $279.</li>\n<li>Mizuho analyst Vijay Rakesh maintained the stock with an Outperform rating and lowered the price target from $310 to $300.</li>\n<li>Wedbush analyst Matt Bryson maintained the stock with an Outperform rating and raised the price target from $280 to $290.</li>\n</ul>\n<p><strong>Considering buying CBRS stock? Here’s what analysts think:</strong></p>\n<figure><img decoding=\"async\" height=\"315\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/08/13091119/image-373-1024x315.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/08/13091119/image-373-1024x315.png 1024w, https://editorial-assets.benzinga.com/wp-content/uploads/2026/08/13091119/image-373-300x92.png 300w, https://editorial-assets.benzinga.com/wp-content/uploads/2026/08/13091119/image-373-768x236.png 768w, https://editorial-assets.benzinga.com/wp-content/uploads/2026/08/13091119/image-373.png 1171w\" width=\"1024\"/></figure>\n<p><em>Photo via Shutterstock</em></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These Analysts Revise Their Forecasts On Cerebras Systems Following Q2 Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese Analysts Revise Their Forecasts On Cerebras Systems Following Q2 Results\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga Earnings </p>\n<p class=\"h-time smaller\">2026-08-13 21:12</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<html><body><p><strong><a href=\"https://laohu8.com/S/CBRS\">Cerebras Systems</a> Inc</strong> (NASDAQ:CBRS) on Wednesday reported worse-than-expected quarterly sales.</p>\n<p>Cerebras Systems reported GAAP quarterly losses of $2.98 per share, according to Benzinga Pro data. Quarterly revenue came in at $180.11 million which missed the Street estimate of $194.2 million by 7.26%.</p>\n<p>\"This was an outstanding quarter for Cerebras. Core revenue more than doubled to $210 million, and our cloud business nearly quadrupled year-over-year,\" said Andrew Feldman, Cerebras co-founder and CEO.</p>\n<p>Cerebras Systems shares dipped 17.6% to $215.98 in pre-market trading.</p>\n<p>These analysts made changes to their price targets on Cerebras Systems following earnings announcement.</p>\n<ul>\n<li>Morgan Stanley analyst Joseph Moore maintained the stock with an Overweight rating and raised the price target from $273 to $279.</li>\n<li>Mizuho analyst Vijay Rakesh maintained the stock with an Outperform rating and lowered the price target from $310 to $300.</li>\n<li>Wedbush analyst Matt Bryson maintained the stock with an Outperform rating and raised the price target from $280 to $290.</li>\n</ul>\n<p><strong>Considering buying CBRS stock? Here’s what analysts think:</strong></p>\n<figure><img decoding=\"async\" height=\"315\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/08/13091119/image-373-1024x315.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/08/13091119/image-373-1024x315.png 1024w, https://editorial-assets.benzinga.com/wp-content/uploads/2026/08/13091119/image-373-300x92.png 300w, https://editorial-assets.benzinga.com/wp-content/uploads/2026/08/13091119/image-373-768x236.png 768w, https://editorial-assets.benzinga.com/wp-content/uploads/2026/08/13091119/image-373.png 1171w\" width=\"1024\"/></figure>\n<p><em>Photo via Shutterstock</em></p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2931357623.SGD","symbol_name":"MANULIFE GF GLOBAL SEMICONDUCTOR OPPORTUNITIES \"AA\" (SGDHDG) ACC","start_time":0,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/08/61173950/these-analysts-revise-their-forecasts-on-cerebras-systems-following-q2-results","article_id":"2659157123","we_media_id":"1052270027","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2659157123","pubTimestamp":1786626740,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Benzinga Earnings","introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"summary":"Cerebras Systems (CBRS) reported worse-than-expected quarterly sales, with GAAP losses of $2.98/share and revenue of $180.11M. Analysts adjusted price targets.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2931357623.SGD":"MANULIFE GF GLOBAL SEMICONDUCTOR OPPORTUNITIES \"AA\" (SGDHDG) ACC","CBRS":"Cerebras Systems","LU0274383776.USD":"MANULIFE GF US SMALL CAP EQUITY \"AA\" (USD) INC","LU2089985449.USD":"MANULIFE GF GLOBAL SEMICONDUCTOR OPPORTUNITIES \"AA\" (USD) ACC","BK4141":"半导体产品"},"translate_title":"这些分析师在第二季度业绩公布后修改了对 Cerebras Systems 的预测","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CBRS":1.5},"content_text":"Cerebras Systems Inc (NASDAQ:CBRS) on Wednesday reported worse-than-expected quarterly sales.\nCerebras Systems reported GAAP quarterly losses of $2.98 per share, according to Benzinga Pro data. Quarterly revenue came in at $180.11 million which missed the Street estimate of $194.2 million by 7.26%.\n\"This was an outstanding quarter for Cerebras. Core revenue more than doubled to $210 million, and our cloud business nearly quadrupled year-over-year,\" said Andrew Feldman, Cerebras co-founder and CEO.\nCerebras Systems shares dipped 17.6% to $215.98 in pre-market trading.\nThese analysts made changes to their price targets on Cerebras Systems following earnings announcement.\n\nMorgan Stanley analyst Joseph Moore maintained the stock with an Overweight rating and raised the price target from $273 to $279.\nMizuho analyst Vijay Rakesh maintained the stock with an Outperform rating and lowered the price target from $310 to $300.\nWedbush analyst Matt Bryson maintained the stock with an Outperform rating and raised the price target from $280 to $290.\n\nConsidering buying CBRS stock? Here’s what analysts think:\n\nPhoto via Shutterstock","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"express","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}